Product
Lansoprazole/Domperidone
1 clinical trial
3 indications
Indication
Gastroesophageal reflux diseaseIndication
Cardiac EventIndication
Safety IssuesClinical trial
Cardiac Safety Evaluation of Lansoprazole/Domperidone 30/30 mg Sustained Release Capsule FormulationStatus: Withdrawn, Estimated PCD: 2018-12-01